Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07225842 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Bridging Antiplatelet Therapy With Cangrelor 2 Study

Name: The Bridging Antiplatelet Therapy With Cangrelor 2 Study — clinical trial record (NCT07225842)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BIRDGE 2

StatusRecruiting

PhasePhase 4

SponsorUniversity of Florida

Started2026-02-18

View on ClinicalTrials.gov ↗

Amendment history

2026-04-30

Study Status, Contacts/Locations v2

Recruitment opened

Start dateestimated 2026-02-25→confirmed 2026-02-18

Study sites0→1

2026-01-21

Study Status v1

Start date2025-11-25→2026-02-25

2025-11-06

Original filing

University of Florida

325 trials monitored

See 23 trials at risk

Coronary Artery Disease

1,518 trials monitored

See 65 trials at risk

The primary aim of this study is to determine rates of patients with optimal platelet reactivity range, defined as PRU levels between 85 and 208, when using a (PFT)-guided titration of cangrelor infusion rate (cangrelor titration) compared to 0.75 mcg/kg/min (standard-dose infusion) for bridging.

Trial Details

NCT Number	NCT07225842
Lead Sponsor	University of Florida
Conditions	Coronary Arterial Disease (CAD)
Enrollment	50 participants
Start Date	2026-02-18
Primary Completion	2027-09 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-05-05